CompletedPhase 4ketamine

The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients

Sponsored by TC Erciyes University

NCT ID
NCT01948336
Target Enrollment
60 participants
Start Date
2012-04
Est. Completion
2013-08

About This Study

The aim of this study is to evaluate the effect of dexmedetomidine infusion on early stage renal function.

Conditions Studied

Renal Function DisorderHemodynamic Instability

Interventions

  • Dexmedetomidine
  • Ketamine
  • Propofol

Eligibility

Age:6 Months - 72 Months
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* 6 and 72 months children
* scheduled for cardiac angiography

Exclusion Criteria:

* patients with renal failure or diabetes mellitus, patients who were on nephrotoxic and vasoactive drugs simultaneously, patients with decompensated congestive heart failure and patients who had been administered contrast media in the last two weeks

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source